Abstract:Abstract Background As the ACHD population ages, an increasing number of patients are being admitted for heart failure. Management is complicated by the limited evidence on pharmacological and other therapies and lack of risk stratification tools. Improved surgical and medical treatment options in this patient cohort has improved life expectancy. Purpose Assess the mortality and rate of rehospitalisation in ACHD patients following admission with decompensated HF and identify clinical predictors of outcome. Methods All ACHD patients admitted for HF requiring IV diuresis from February 2016 to December 2020 in a single tertiary centre were included. Cox analysis was used to identify predictors of death after the index admission. Results 91 patients were included: 44.0% female, 45.8±14.2 years. The most frequent underlying diagnoses were: 15.4% with primary valve or left ventricular outflow tract disease, 12.1% with transposition of the great arteries post-atrial switch, 9.9% with tetralogy of Fallot and 30.8% had a systemic right ventricle. Most (56.7%) patients had CHD of “great” complexity according to the Bethesda classification, whereas no patients had “simple” CHD. Cyanosis was present in 26.4%. Heart failure was predominantly related to systemic ventricular dysfunction in 35.2%, subpulmonary ventricular dysfunction in 25.3%, biventricular dysfunction in 24.2% and univentricular dysfunction in 15.4%. Pulmonary hypertension was present in most (58.2%) patients, only half (46.0%) of these had pre-capillary pulmonary hypertension. On admission, approximately half of patients were on standard heart failure therapy: 48.4% ACE-inhibitors or angiotensin receptor blockers, 54.9% beta-blockers, 54.9% mineralocorticoid receptor antagonists and 2% on sacubitril/valsartan. In-hospital mortality was only 3.3% in this high-risk population. During a median follow-up of 22.1 [0.2–58.4] months, 37.5% patients were rehospitalised for HF and 37.5% patients died (22.7% mortality at 1 year). On univariable Cox analysis, the following parameters were predictors of mortality: pulmonary hypertension, cyanosis, unoperated or palliated CHD, chronic kidney disease (CKD), hyponatraemia, mineralocorticoid receptor antagonist use on admission, admission BNP>350ng/L and a maximum daily inpatient loop diuretic requirement >160mg (furosemide equivalents). On multivariable Cox analysis, pulmonary hypertension, cyanosis, hyponatraemia and CKD were independent predictors of mortality; patients with ≥2 of these risk factors had an 8-fold higher mortality (figure). Conclusion ACHD patients hospitalised for decompensated HF have a poor outlook with a quarter of patients dying within a median <2 years from discharge. We present clinical parameters that can identify patients at high risk of an adverse outcome who should be targeted for aggressive monitoring and advanced HF therapies, including transplantation. Funding Acknowledgement Type of funding sources: None. Figure 1

Survival in acute heart failure in intensive cardiac care unit: a prospective study

ACUTE HF score, a multiparametric prognostic tool for acute heart failure: A real-life study

Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure

Clinical presentation and outcomes of acute heart failure in the critically ill patient: A prospective, observational, multicentre study

Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure.

Predictors of Long-Term Mortality in Patients with Acute Heart Failure.

Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group

Predicting One-Year Mortality after Discharge Using Acute Heart Failure Score (AHFS)

MELD score as predictor of mortality in patients with advanced heart failure: a longitudinal evaluation

Predictors of Adverse Clinical Outcome after Hospitalisation for Decompensated Heart Failure in ACHD Patients

Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry

Prediction of cardiac worsening through to cardiogenic shock in patients with acute heart failure

Mortality prediction in acute heart failure: scores or biomarkers?

Activity of the adrenomedullin system to personalise post-discharge diuretic treatment in acute heart failure

Diagnosis and Treatment of Acute Heart Failure: A Retrospective Observational Study and Medical Audit

A novel score to predict in-hospital mortality for patients with acute coronary syndrome and out-of-hospital cardiac arrest: the FACTOR study

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

Early and short-term intensive management after discharge for patients hospitalized with acute heart failure: a randomized study (ECAD-HF)

An Early Warning Scoring System for the Prevention of Acute Heart Failure.

Studying Predictors of Acute Left Ventricular Failure and Criteria for the Progression of Chronic Heart Failure in Cardiac Pathologies (Literature Review: Results of Own Research)

The HEARTRISK6 Scale: Predicting Short-Term Serious Outcomes in Emergency Department Acute Heart Failure Patients